Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jennifer C. Howell"'
Autor:
Andreas Giannisis, Asma Al-Grety, Henrik Carlsson, Jennifer C. Howell, William T. Hu, Kim Kultima, Henrietta M. Nielsen
Publikováno v:
Alzheimer’s Research & Therapy, Vol 15, Iss 1, Pp 1-19 (2023)
Abstract Background The APOEε4-promoted risk of Alzheimer’s disease (AD) is lower in Black/African-Americans (B/AAs), compared to non-Hispanic whites (NHWs). Previous studies reported lower plasma apolipoprotein E (apoE) levels in NHW APOEε4-carr
Externí odkaz:
https://doaj.org/article/9d920d8987be435a8cabbddb33f40453
Autor:
Yanaika S. Hok-A-Hin, Jeroen J. M. Hoozemans, William T. Hu, Dorine Wouters, Jennifer C. Howell, Alberto Rábano, Wiesje M. van der Flier, Yolande A. L. Pijnenburg, Charlotte E. Teunissen, Marta del Campo
Publikováno v:
Alzheimer’s Research & Therapy, Vol 14, Iss 1, Pp 1-11 (2022)
Abstract Background YKL-40 (Chitinase 3-like I) is increased in CSF of Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD) patients and is therefore considered a potential neuroinflammatory biomarker. Whether changed YKL-40 levels
Externí odkaz:
https://doaj.org/article/119f87756ba34fef8a830eeee371d12b
Autor:
Andreas Giannisis, Asma Al-Grety, Henrik Carlsson, Jennifer C. Howell, William T. Hu, Kim Kultima, Henrietta M. Nielsen
Publikováno v:
Alzheimer’s Research & Therapy, Vol 15, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/0f41bf48829f4ad3911e4397221af1ac
Autor:
Jennifer C. Howell, Kelly D. Watts, Monica W. Parker, Junjie Wu, Alexander Kollhoff, Thomas S. Wingo, Cornelya D. Dorbin, Deqiang Qiu, William T. Hu
Publikováno v:
Alzheimer’s Research & Therapy, Vol 9, Iss 1, Pp 1-10 (2017)
Abstract Background African Americans have been reported to have a higher prevalence of Alzheimer’s disease (AD) than Caucasians, but etiology-specific AD biomarkers have not been systematically analyzed in older African Americans. Coexisting cereb
Externí odkaz:
https://doaj.org/article/4cc6710c2b3e4de289fd47f8d9a2fd33
Publikováno v:
Frontiers in Aging Neuroscience, Vol 10 (2018)
Cerebrospinal fluid (CSF) biomarkers can enhance the early and accurate etiologic detection of Alzheimer’s disease (AD) even when symptoms are very mild, but are not yet widely available for clinical testing. There are a number of reasons for this,
Externí odkaz:
https://doaj.org/article/3e4d372131164e979d454fd8fb436344
Autor:
Gary W. Miller, William T. Hu, Jennifer C. Howell, Douglas I. Walker, Megan M. Niedzwiecki, Dean P. Jones, Kelly D. Watts
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 7, Iss 1, Pp 36-45 (2020)
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology
Background Alzheimer’s disease (AD) is a complex neurological disorder with contributions from genetic and environmental factors. High‐resolution metabolomics (HRM) has the potential to identify novel endogenous and environmental factors involved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9778131df18895dce99e5ec90a57002
https://doaj.org/article/e51ef293ea304ab1bcb808a1ccb78c7c
https://doaj.org/article/e51ef293ea304ab1bcb808a1ccb78c7c
Autor:
Thomas S. Wingo, Cornelya D. Dorbin, Alexander L. Kollhoff, Deqiang Qiu, William T. Hu, Kelly D. Watts, Jennifer C. Howell, Junjie Wu, Monica W. Parker
Publikováno v:
Alzheimer’s Research & Therapy, Vol 9, Iss 1, Pp 1-10 (2017)
Alzheimer's Research & Therapy
Alzheimer's Research & Therapy
Background African Americans have been reported to have a higher prevalence of Alzheimer’s disease (AD) than Caucasians, but etiology-specific AD biomarkers have not been systematically analyzed in older African Americans. Coexisting cerebrovascula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca10005979fe216604689ed2a6aa1748
http://link.springer.com/article/10.1186/s13195-017-0315-1
http://link.springer.com/article/10.1186/s13195-017-0315-1
Autor:
John Q. Trojanowski, Jennifer C. Howell, Kelly D. Watts, Jonathan D. Glass, William T. Hu, James J. Lah, Leslie M. Shaw, Allan I. Levey, Sundeep Basra
Publikováno v:
Annals of Clinical and Translational Neurology
Objective To characterize biological and technical factors which influence cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarker levels, including the presence of apolipoprotein E (APOE) ε4 allele, AD diagnosis, Aβ-binding proteins, sample p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae37c8eb5362987b57ea596969f41b1
http://europepmc.org/articles/PMC4338954
http://europepmc.org/articles/PMC4338954
Autor:
Monica W. Parker, Sharon H Bergquist, Jennifer C. Howell, Alexander L. Kollhoff, William T. Hu, Dobromira Z. Tsvetkova, Kelly D. Watts, David L. Roberts, Thomas L. Jarrett
Publikováno v:
Frontiers in Aging Neuroscience
Cerebrospinal fluid biomarkers for Alzheimer’s disease and related disorders can provide early and accurate prediction of underlying neuropathology even when the clinical symptoms are mild, but lumbar punctures (LP) to obtain cerebrospinal fluid ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::760b543bee909a4c471221d2017b8bdf
Autor:
Jennifer C. Howell, William T. Hu, Kelly D. Watts, Alexander L. Kollhoff, Monica W. Parker, Dobromira Z. Tsvetkova
Publikováno v:
Frontiers in Aging Neuroscience, Vol 8 (2016)
Frontiers in Aging Neuroscience
Frontiers in Aging Neuroscience
African Americans are under-represented in Alzheimer’s disease (AD)-related biomarker studies, and it has been speculated that mistrust plays a major factor in the recruitment of African Americans for studies involving invasive procedures such as t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e20f4dc822be719cbd1a9dcc74fec99
http://journal.frontiersin.org/Journal/10.3389/fnagi.2016.00296/full
http://journal.frontiersin.org/Journal/10.3389/fnagi.2016.00296/full